Cargando…

Noninvasive biomarkers FibroTest and ActiTest versus liver biopsy in chronic hepatitis C patients: the Middle East experience

BACKGROUND: The aim of this study was to compare noninvasive biomarkers, FibroTest and ActiTest in predicting fibrosis stage and inflammation grade in chronic hepatitis C (CHC) patients with liver biopsy (LB). METHODS: In 107 patients with CHC, levels of six serum biomarkers (alanine aminotransferas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yakoob, Rafie, Bozom, Issam Al, Thandassery, Ragesh Babu, Rahman, Mohamed Osman Abdel, Derbala, Moutaz F., Mohannadi, Muneera J. Al, John, Anil K., Sharma, Manik, Wani, Hamidulla, Kaabi, Saad Al
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367218/ https://www.ncbi.nlm.nih.gov/pubmed/25830472

Ejemplares similares

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference
por: Munteanu, M., et al.
Publicado: (2016)

Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)
por: Munteanu, Mona, et al.
Publicado: (2004)

Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus
por: Bril, Fernando, et al.
Publicado: (2019)

Clinical Application of AIMS65 Scores to Predict Outcomes in Patients with Upper Gastrointestinal Hemorrhage
por: Thandassery, Ragesh Babu, et al.
Publicado: (2015)

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C
por: Poynard, Thierry, et al.
Publicado: (2004)

Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data
por: Poynard, Thierry, et al.
Publicado: (2012)

An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load
por: Ngo, Yen, et al.
Publicado: (2008)

Correction: An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load
por: Ngo, Yen, et al.
Publicado: (2008)

A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease
por: Halfon, Philippe, et al.
Publicado: (2002)

Non-invasive evaluation of the liver disease severity in children with chronic viral hepatitis using FibroTest and ActiTest – comparison with histopathological assessment
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2017)

Large fundal varices: to glue or not to glue?
por: Mohiuddin, Syed Adnan, et al.
Publicado: (2014)

High Dose of Lamivudine and Resistance in Patients with Chronic Hepatitis B
por: Wani, Hamid Ullah, et al.
Publicado: (2014)

Uncommon gastrointestinal complications of enteric fever in a non-endemic country
por: Thandassery, Ragesh Babu, et al.
Publicado: (2014)

Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis
por: Friedrich-Rust, Mireen, et al.
Publicado: (2010)

Meta-analyses of FibroTest diagnostic value in chronic liver disease
por: Poynard, Thierry, et al.
Publicado: (2007)

Discordance between Liver Biopsy and FibroTest in Assessing Liver Fibrosis in Chronic Hepatitis B
por: Park, Mi Sung, et al.
Publicado: (2013)

Intra-abdominal desmoplastic small round cell tumor
por: Thandassery, Ragesh Babu, et al.
Publicado: (2014)

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
por: Ratziu, Vlad, et al.
Publicado: (2006)

Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age
por: Poynard, Thierry, et al.
Publicado: (2011)

Reexamination of the relationship between the prevalence of hepatitis C virus and parenteral antischistosomal therapy among Egyptians resident in Qatar
por: Derbala, Moutaz, et al.
Publicado: (2014)

Prospective Validation of ELF Test in Comparison with Fibroscan and FibroTest to Predict Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
por: Kim, Beom Kyung, et al.
Publicado: (2012)

Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)
por: Poynard, Thierry, et al.
Publicado: (2010)

Prospective Validation of FibroTest in Comparison with Liver Stiffness for Predicting Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
por: Kim, Beom Kyung, et al.
Publicado: (2012)

FibroTest for Evaluating Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-Analysis
por: Vali, Yasaman, et al.
Publicado: (2021)

Prostate cancer metastases to the rectum: A case report
por: Abbas, Tariq O, et al.
Publicado: (2011)

Long‐term prognostic value of the FibroTest in patients with non‐alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease
por: Munteanu, Mona, et al.
Publicado: (2018)

Extensive cervical, thoracic, and abdominal wall emphysema and pneumomediastinum following ERCP: a rare scenario
por: John, Anil K, et al.
Publicado: (2014)

Extensive cervical, thoracic, and abdominal wall emphysema and pneumomediastinum following ERCP: a rare scenario
por: John, Anil K, et al.
Publicado: (2014)

Gastric glomus tumor presenting with massive upper GI bleeding: A challenging to diagnose and treat tumor
por: Ayash, Ahmad, et al.
Publicado: (2022)

Down the wrong road – a case report of inadvertent nasogastric tube insertion leading to lung laceration and important pearls to avoid complications
por: Mohiuddin, Syed Adnan, et al.
Publicado: (2017)

UCx Prototype Target Tests for ActiLab-ENSAR
por: Andrighetto, A; INFN-LNL, et al.
Publicado: (2011)

UC$_{x}$ prototype target tests for ActiLab-ENSAR
por: Andrighetto, A, et al.
Publicado: (2012)

Laudator Temporis Acti
Publicado: (1905)

Gene Expression Profiling of FFPE Samples: A Titration Test
por: Manjunath, Harshitha Shobha, et al.
Publicado: (2022)

Hepatocellular carcinoma in Hepatitis C genotype 4 after viral clearance and in absence of cirrhosis: two case reports
por: Derbala, Moutaz, et al.
Publicado: (2009)

SAFETY AND EFFECTIVENESS OF THE BNT162B2 MRNA COVID-19 VACCINE IN A NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Khan, Muhammad, et al.
Publicado: (2022)

Memores Acti Prudentes Future!
por: Kulkarni, Atul P, et al.
Publicado: (2022)

Increased Diagnosis of Hepatocellular Carcinoma in Hospitalized Patients with Alcohol Related Hepatitis after the Covid-19 Outbreak: A Global Multi-Center Propensity Matched Analysis
por: Perisetti, Abhilash, et al.
Publicado: (2021)

Prevalence and trends of transfusion transmissible infections among blood donors in the State of Qatar, 2013–2017
por: Aabdien, Mohamed, et al.
Publicado: (2020)

PD−L1 immunostaining: what pathologists need to know
por: Akhtar, Mohammed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2pgnjqe1417f4nfrtdmsbbe55t